Sun Pharma Advanced Research (SPARC.BO) Earnings Analysis
Sun Pharma Advanced Research (SPARC.BO) has no confirmed upcoming earnings date. It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 4.48.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SPARC.BO next report earnings?
No confirmed upcoming earnings date is currently scheduled for SPARC.BO. This page updates as the calendar is published.
SPARC.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-18 | 54.27 INR | n/a | n/a | n/a |
| 2026-02-09 | -2.48 INR | n/a | n/a | n/a |
| 2025-11-03 | -2.34 INR | n/a | n/a | n/a |
| 2025-08-04 | -1.6 INR | n/a | n/a | n/a |
| 2025-05-19 | -1.84 INR | n/a | n/a | n/a |
| 2025-02-10 | -2.45 INR | n/a | n/a | n/a |
| 2024-11-04 | -3.31 INR | 12.7 INR | -126.1% | Miss |
| 2024-08-05 | -2.96 INR | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
SPARC.BO valuation and analyst view
| Trailing P/E | 4.48 |
|---|---|
| Trailing EPS | 47.857 INR |
| Price / book | 5.20 |
| Dividend yield | 0.00% |
| Market cap | 69.39B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sun Pharma Advanced Research (SPARC.BO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for SPARC.BO. This page updates as the calendar is published.
Did SPARC.BO beat earnings last quarter?
Consensus estimate data was not available for SPARC.BO's 2026-05-18 report.
What is SPARC.BO's earnings track record?
Over the last 1 reported quarters with consensus data, SPARC.BO beat estimates 0 times (0%).
What is SPARC.BO's current P/E ratio and EPS?
SPARC.BO trades at a trailing P/E of 4.48 on trailing EPS of 47.85688535854149 INR.
What do analysts rate SPARC.BO?
SPARC.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.